Specialized astrocyte subpopulation discovery sheds light on brain health and treatment avenues

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

In a recent study published in Nature, researchers investigated whether glutamatergic gliotransmission was mediated by specialized astrocytes in the central nervous system.

The role of astrocytes in brain circuitry function, such as swift glutamate release, has been questioned due to inconsistent data and lack of direct evidence. This mechanism, similar to neurons, controls plasticity, excitability, and coordinated activity of synaptic-type networks but also contributes to neuropsychiatric conditions.

A cross-species evaluation was performed by referencing three hippocampal cell databases. fluorescence in-situ hybridization analysis was performed to analyze hippocampal slices from adult murine cells co-immunostained with astrocytic markers such as GS and S100β. The researchers applied clozapine N-oxide through brief puffs locally followed by L-glutamate application as a control. To determine whether astrocyte release occurred through exocytosis, the team sought to impede glutamate filling in vesicles.

Related StoriesThey also discovered a matching astrocyte subgroup that reliably reacted to astrocyte-specific stimulations with sub-second release of glutamate at geographically specific areas of greatest need, which was inhibited by astrocyte-targeted VGLUT1 ablation. Glutamate release responses always took place at specific hotspots of an astrocyte, providing direct functional evidence for the existence of a specialized population of glutamatergic astrocytes predicted by transcriptomic studies. The team found a robust correlation between the physiological and molecular identification of glutamatergic astrocytes.

Astrocyte VGLUT2-dependent signaling regulated nigrostriatal dopaminergic pathway function in vivo, representing a potential therapeutic target for Parkinson's disease.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines